GleamWall
中文EN

MCAG Mountain Crest Acquisition Corp. V

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1859035 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY79.0%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-9.6%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets414.1%
Debt / equity—
Current ratio0.05x
Interest coverage—

Cash quality & payout

Operating cash flow / net income5.57x
Accruals ratio43.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
SG&A expense$471,782$618,486
Operating income-$471,782-$618,486
Interest expense—$1,402
Pretax income-$422,267-$328,558
Income tax$8,894$45,896
Net income-$431,161-$374,454
EPS (diluted)——
Balance sheet
Cash & equivalents$11,909$116,658
Current assets$32,927$156,779
Total assets$873,566$1.31M
Current liabilities$1.65M$1.52M
Total liabilities$3.72M$3.59M
Shareholders' equity-$3.68M-$3.44M
Shares outstanding2.80M2.80M
Cash flow statement
Operating cash flow-$741,998-$921,200
Investing cash flow$362,787$4.72M
Financing cash flow$274,462-$3.70M

Free plan shows the latest 2 periods; Pro shows all 4 🔒

· This company does not report gross profit in XBRL.

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.